SYRE vs MSFT: Which Stock is Better?
Side-by-side comparison of Spyre Therapeutics Inc and Microsoft Corp in 2026
SYRE
Spyre Therapeutics Inc
$73.01
MSFT
Microsoft Corp
$430.11
Key Metrics Comparison
| Metric | SYRE | MSFT | Winner |
|---|---|---|---|
| Market Cap | $5.94B | N/A | SYRE |
| P/E Ratio | N/A | 26.32 | MSFT |
| EPS (TTM) | $N/A | $15.97 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 0.0% | 68.6% | MSFT |
Analyze SYRE
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRE or MSFT a better investment?
Comparing SYRE and MSFT: Spyre Therapeutics Inc has a market cap of $5.94B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRE and MSFT?
SYRE (Spyre Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRE or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRE or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for SYRE.
Which company is more profitable: SYRE or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 0.0% for SYRE.
Which is the larger company: SYRE or MSFT?
Spyre Therapeutics Inc (SYRE) is larger with a market cap of $5.94B compared to N/A for MSFT.
Should I buy SYRE or MSFT in 2026?
Both SYRE and MSFT have investment merit. SYRE trades at $73.01 while MSFT trades at $430.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRE and MSFT stock?
Key differences: Market Cap ($5.94B vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 68.6%).